- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01423773
Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue Compression
June 20, 2013 updated by: CIBA VISION
The purpose of this study was to compare the fit and comfort of two types of contact lenses.
Study Overview
Status
Completed
Conditions
Detailed Description
The relationship between ocular comfort and the Optical Coherence Tomography (OCT) measurements of post lens clearance and ocular tissue compression was studied.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33136
- McKnight Building, Bascom Palmer Eye Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Be of legal age of consent and sign Informed Consent document.
- Normal binocularity.
- Be able to wear soft contact lenses.
- Willing to comply with the wear and study visit schedule.
- Spherical contact lens prescription within 0.50 diopter of the available lens powers.
- Spectacle cylinder less than or equal to 1.50 diopter.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Eye injury or surgery within twelve weeks of enrollment.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Currently enrolled in any clinical trial.
- Evidence of systemic or ocular abnormality, infection, or disease likely to affect successful wear of contact lenses or use of accessory solutions as determined by the investigator.
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Lotrafilcon A test/lotrafilcon A control
Lotrafilcon A test contact lens worn first, with lotrafilcon A control contact lens worn second.
Each product worn bilaterally for two days as follows: 20 minutes on Day 1 and 10 hours on Day 2.
|
Silicone hydrogel single vision, soft contact lens with alternate parameters
Silicone hydrogel single vision, soft contact lens
Other Names:
Investigational, nonsignificant risk device for measuring post lens clearance and ocular tissue compression during contact lens wear
|
|
Other: Lotrafilcon A control/lotrafilcon A test
Lotrafilcon A control contact lens worn first, with lotrafilcon A test contact lens worn second.
Each product worn bilaterally for two days as follows: 20 minutes on Day 1 and 10 hours on Day 2.
|
Silicone hydrogel single vision, soft contact lens with alternate parameters
Silicone hydrogel single vision, soft contact lens
Other Names:
Investigational, nonsignificant risk device for measuring post lens clearance and ocular tissue compression during contact lens wear
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Final Comfort
Time Frame: Day 2, Hour 10
|
Comfort was assessed by the participant on a Visual Analog Scale of 0 to 100, where 0=Extremely Uncomfortable ("My eyes are in pain.
I cannot tolerate my lenses") and 100=Extremely Comfortable ("My eyes feel GREAT, better than normal.
I cannot feel my lenses").
|
Day 2, Hour 10
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jianhua Wang, MD, PhD, Bascom Palmer Eye Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2011
Primary Completion (Actual)
December 1, 2011
Study Completion (Actual)
December 1, 2011
Study Registration Dates
First Submitted
August 25, 2011
First Submitted That Met QC Criteria
August 25, 2011
First Posted (Estimate)
August 26, 2011
Study Record Updates
Last Update Posted (Estimate)
June 28, 2013
Last Update Submitted That Met QC Criteria
June 20, 2013
Last Verified
November 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- P-367-C-800
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ocular Comfort
-
Alcon ResearchCompleted
-
Laboratorios Sophia S.A de C.V.CompletedTolerability | Safety | Ocular Surface | Ocular ComfortMexico
-
Bausch & Lomb IncorporatedCompleted
-
National Center for Occupational Health and Infection...VA Office of Research and DevelopmentCompletedTolerability | ComfortUnited States
-
Centre Hospitalier Universitaire de NīmesCompleted
-
Ohio State UniversityNational Eye Institute (NEI); National Institutes of Health (NIH)Completed
-
Funda Kardas OzdemirCompletedStress | ComfortTurkey (Türkiye)
-
University of British ColumbiaCompleted
-
St. John Health System, MichiganCompletedPatient ComfortUnited States
-
Medtronic - MITGInstitute for Skin Research, IsraelCompleted
Clinical Trials on Lotrafilcon A test contact lens
-
CIBA VISIONCompleted
-
CIBA VISIONUniversity of WaterlooCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
CIBA VISIONCompleted
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
CIBA VISIONCompleted